TB Evenlode Global Income: dividends, vaccines and their biggest success

Ben Peters and Chris Elliott, co-managers of TB Evenlode Global Income fund update us on how the fund’s dividends have held up [0:20], how they’ve spilt their portfolio into three buckets following the pandemic [1:33] and what effect vaccine news, if any, has had on the fund [3:30]. Finally, as the fund just reached its 3 year anniversary we ask the managers which area has become more interesting [4:28] and which stock has been their biggest success [5:17].

This article is provided for information only. The views of the author and any people quoted are their own and do not constitute financial advice. The content is not intended to be a personal recommendation to buy or sell any fund or trust, or to adopt a particular investment strategy. However, the knowledge that professional analysts have analysed a fund or trust in depth before assigning them a rating can be a valuable additional filter for anyone looking to make their own decisions. Past performance is not a reliable guide to future returns. Remember, all investments can fall in value as well as rise, so you could make a loss. Before you make any investment decision, make sure you’re comfortable and fully understand the risks.Further information can be found on Elite Rated funds by simply clicking on the name highlighted in the article.

Related content